The NF-κB signaling pathway (Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells) is involved in the development and progression of MM, contributing to drug resistance [15]. The gene discussed is NFKB1; the disease is Miyoshi myopathy.